BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30815771)

  • 1. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.
    Najafi Z; Sharifi M; Javadi G
    J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R
    Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma.
    Najafi Z; Sharifi M; Javadi G
    Cancer Gene Ther; 2015 Nov; 22(11):530-5. PubMed ID: 26427512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 5. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
    Kaur R; Kanthaje S; Taneja S; Dhiman RK; Chakraborti A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
    Grossi I; Arici B; Portolani N; De Petro G; Salvi A
    Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5.
    Liu T; Zhang X; Sha K; Liu X; Zhang L; Wang B
    Cell Prolif; 2015 Jun; 48(3):330-7. PubMed ID: 25818666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
    Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
    Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J; Jiang C; Liu B; Fang S; Kuang M
    Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
    Zhuang L; Wang X; Wang Z; Ma X; Han B; Zou H; Wu Z; Dong S; Qu Z; Zang Y; Wu L
    Cell Death Dis; 2017 May; 8(5):e2804. PubMed ID: 28518144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-20a inhibition using locked nucleic acid (LNA) technology and its effects on apoptosis of human macrophages infected by Toxoplasma gondii RH strain.
    Rezaei F; Daryani A; Sharifi M; Sarvi S; Jafari N; Pagheh AS; Hashemi N; Hejazi SH
    Microb Pathog; 2018 Aug; 121():269-276. PubMed ID: 29800695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA-30a inhibits proliferation of hepatocellular carcinoma cells via targeted regulation of forkhead-box protein A1].
    Li Y; Fu L; Fu XY; Li RH; Peng SF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):706-711. PubMed ID: 29108194
    [No Abstract]   [Full Text] [Related]  

  • 17. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
    He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
    He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
    Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R
    Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.